Immune Tolerance Network (UM1 Clinical Trial Required)

This grant supports the Immune Tolerance Network, which develops tolerogenic therapies for immune-mediated disorders. It funds clinical trial design, conduct, and result sharing, plus integrated mechanistic studies, focusing on allergic diseases and asthma, autoimmune diseases, and immune-mediated consequences of transplantation.

Amount: Not stated
Type: Grant

Key facts

Key facts for Immune Tolerance Network (UM1 Clinical Trial Required)
Amount	Not stated
Issuer	National Institutes of Health
Who can apply	Small businesses, companies, universities and 7 more
Sectors	HealthTech
Deadline	Closes 29 Jan 2027

Unlock application details

See all eligibility criteria, required documents and the official application link. Free account, no card.

Update history

Source: grants.gov ↗

Source checked 3 days ago

18 days agoagentImported from the official source

Opportunities with the same funding type or region
European Degree Exploratory Action		Closes 18 Feb 2027
Cooperative Agreement for affiliated Partner with Alaska Cooperative Ecosystem Studies Unit	up to $234,460	Closes 07 Dec 2026
Cooperative Agreement for affiliated Partner with Colorado Plateau Cooperative Ecosystem Studies Unit	up to $150,000	Closes 07 Dec 2026